soul trial oral semaglutide cardiovascular outcomes results 2024 2025 (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine soul trial oral semaglutide cardiovascular

In their new study, Sahingur and her team used the dasatinib-quercetin (DQ) combination, a senotherapy that has shown an ability to reduce senescent cell numbers and senescence markers in other clinical contexts

In men, Tongkat Ali may help activate hormones that stimulate the testicles to produce testosterone

Key Benefits & Added Enhancements: GLP-1 Activation & Appetite Regulation:Berberine, EGCG (Green Tea 50%), CLA, Tesofensine, Chromium, and Cinnamon Extract stimulate GLP-1 release, regulate appetite, and improve glycemic control, supporting fat metabolism, satiety, and insulin efficiency

10.1038/nature09944 Nature 7 AtashrazmF.HammondD.PereraG.Dobson-StoneC.MuellerN.PickfordR.et al (2018)

10.1158/1078-0432.CCR-19-3975 250 YangJ.ZhouY.XieS.WangJ.LiZ.ChenL.et al (2021)

It does not alter urinary glucose levels